Dusseldorf - Delayed Quote • EUR
Biocartis Group NV (8XB.DU)
As of September 25 at 8:11 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
60,612.0000
57,481.0000
48,269.0000
43,128.0000
Cost of Revenue
29,457.0000
29,799.0000
33,922.0000
26,284.0000
Gross Profit
31,155.0000
27,682.0000
14,347.0000
16,844.0000
Operating Expense
73,921.0000
74,433.0000
76,645.0000
63,226.0000
Operating Income
-42,766.0000
-46,751.0000
-62,298.0000
-46,382.0000
Net Non Operating Interest Income Expense
-24,025.0000
-17,690.0000
-8,411.0000
-15,768.0000
Pretax Income
-68,035.0000
-65,621.0000
-71,715.0000
-63,162.0000
Tax Provision
-167.0000
-240.0000
-243.0000
-228.0000
Net Income Common Stockholders
-67,868.0000
-65,381.0000
-71,472.0000
-62,934.0000
Diluted NI Available to Com Stockholders
-67,868.0000
-65,381.0000
-71,472.0000
-62,934.0000
Basic EPS
-0.92
-1.08
-1.24
-0.95
Diluted EPS
-0.92
-1.08
-1.24
-0.95
Basic Average Shares
78,389.2780
60,546.4650
57,545.6630
66,380.8470
Diluted Average Shares
78,389.2780
60,546.4650
57,545.6630
66,380.8470
Total Operating Income as Reported
-43,183.0000
-47,047.0000
-62,645.0000
-46,862.0000
Total Expenses
103,378.0000
104,232.0000
110,567.0000
89,510.0000
Net Income from Continuing & Discontinued Operation
-67,868.0000
-65,381.0000
-71,472.0000
-62,934.0000
Normalized Income
-67,455.0162
-65,088.0753
-71,127.1724
-62,455.7327
Interest Income
--
--
1,077.0000
--
Interest Expense
16,091.0000
11,187.0000
9,320.0000
10,184.0000
Net Interest Income
-24,025.0000
-17,690.0000
-8,411.0000
-15,768.0000
EBIT
-51,944.0000
-54,434.0000
-62,395.0000
-52,978.0000
EBITDA
-41,561.0000
-43,953.0000
-52,550.0000
-43,230.0000
Reconciled Cost of Revenue
29,457.0000
29,799.0000
33,922.0000
26,284.0000
Reconciled Depreciation
10,383.0000
10,481.0000
9,845.0000
9,748.0000
Net Income from Continuing Operation Net Minority Interest
-67,868.0000
-65,381.0000
-71,472.0000
-62,934.0000
Total Unusual Items Excluding Goodwill
-414.0000
-294.0000
-346.0000
-480.0000
Total Unusual Items
-414.0000
-294.0000
-346.0000
-480.0000
Normalized EBITDA
-41,147.0000
-43,659.0000
-52,204.0000
-42,750.0000
Tax Rate for Calcs
0.0000
0.0000
0.0000
0.0000
Tax Effect of Unusual Items
-1.0162
-1.0753
-1.1724
-1.7327
12/31/2020 - 6/15/2021
Yahoo Finance Plus Essential access required. Unlock Access